Rx Response

07.23.13 | By

Big storms – like Sandy, like Katrina – happen. The toll can be devastating.  Proper preparation to meet the human, logistical and supply-chain problems that come along with a big storm is critical.

'Conversations' Round Up

07.22.13 | By

Last week’s ‘Conversations’ question “What steps should the U.S. take to protect and strengthen IP rights domestically and overseas?” prompted interesting responses from the U.S.

Week in Review: Paving the Way for Innovative Medicines

07.19.13 | By

The biopharmaceutical community has made tremendous progress in recent years developing innovative treatments for chronic conditions, thanks to advancements in science and medicine.  Not only do these advancements improve people’s lives every day, they also provide hope that we may one day be able to prevent or cure diseases like Alzheimer’s, cancer and HIV/AIDS.  This week, the Catalys

PhRMA Endorses FDA Safety Over Sequestration Act

WASHINGTON, D.C. (July 22, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, PhD, issued the following statement today on ongoing efforts in Congress to resolve the sequestration of prescription drug user fees:

“PhRMA remains deeply concerned about the impact of sequestration on the Food and Drug Administration’s (FDA) ability to fulfill its critical public health mission by fostering timely patient access to safe and effective new medicines and advancing regulatory science.

Importance of Detecting Alzheimer's Disease

07.18.13 | By

Today Show contributor Linda Carroll wrote a great article about the importance of detecting Alzheimer's disease earlier in life.

Protecting Intellectual Property

07.16.13 | By

This week in Malaysia, the United States continues Trans-Pacific Partnership (TPP) negotiations with many of its most important Asia-Pacific trading partners. As we’ve discussed extensively on the Catalyst, through TPP the U.S. aims to expand trade and exports, create new jobs, and help secure its competitive standing in the global marketplace.

Research at May Clinic

07.16.13 | By

I’m not talking about a broken heart from love, but rather from heart disease.

Individualized care, new innovations key to stemming the tide of chronic disease

07.15.13 | By

A chronic disease is detrimental to more than just the person who has it – its impact ripples through the health care system and economy as a whole. According to research by the Robert Wood Johnson Foundation, 80 cents of every dollar spent on health care in the United States goes to treat chronic disease. Its significance cannot be overstated.

Week in Review: Supporting the Fight Against Chronic Disease

07.12.13 | By

The increasing burden of chronic diseases, as well as potential solutions to the problem, were a major focus for us this week.

Amicus Brief in FTC v. Actavis

Pages

Subscribe to RSS - Opinion